The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 study of axitinib + nivolumab in mucosal melanoma with pilot addition of stereotactic body radiotherapy or ipilimumab in select progressors.
 
Sarah Lochrin
Travel, Accommodations, Expenses - Novartis
 
Hannah Kalvin
No Relationships to Disclose
 
Monica Chen
Stock and Other Ownership Interests - docs; FIGS; Nordisk; Quest Diagnostics
Consulting or Advisory Role - Candel Therapeutics
Research Funding - ASCO; NIH
Travel, Accommodations, Expenses - AACR; ASCO
 
James Smithy
Consulting or Advisory Role - Bristol-Myers Squibb; IO Biotech; Iovance Biotherapeutics
Research Funding - Daiichi Sankyo (Inst); IO Biotech (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Immatics
 
Parisa Momtaz
No Relationships to Disclose
 
Michael Postow
Consulting or Advisory Role - Bristol-Myers Squibb; Cancer Expert Now; Chugai Pharma; Eisai; Erasca, Inc; Intellisphere; Lyvgen Biopharma; Merck; MJH Associates; Nektar; Novartis; Pfizer; WebMD
Research Funding - Array BioPharma (Inst); BioAtla (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); ImaginAb (Inst); Infinity Pharmaceuticals (Inst); Merck (Inst); Novartis (Inst); Rgenix (Inst)
 
Shirlanna Station
No Relationships to Disclose
 
Amanda Hill
No Relationships to Disclose
 
Charlene Hochreiter
No Relationships to Disclose
 
Roseann Durak
No Relationships to Disclose
 
Katherine Panageas
Stock and Other Ownership Interests - 23andMe; EyePoint Pharmaceuticals (I); Kyverna Therapeutics (I); Vincerx Pharma
Research Funding - AACR (Inst)
Travel, Accommodations, Expenses - AACR Project GENIE; The Robert A. Winn Diversity in Clinical Trials Award Program (Winn Awards) in collaboration with the American Association for Cancer Research (AACR), Bristol Myers Squibb Foundation
 
Randy Yeh
No Relationships to Disclose
 
Christopher Barker
Consulting or Advisory Role - Regeneron
Research Funding - Alpha TAU Medical (Inst); Amgen (Inst); Elekta (Inst); EMD Serono/Merck (Inst); PSI (Inst); Regeneron (Inst)
 
Alexander Shoushtari
Consulting or Advisory Role - Erasca, Inc; Immunocore
Research Funding - Bristol-Myers Squibb (Inst); IDEAYA Biosciences (Inst); Immunocore (Inst); Iovance Biotherapeutics (Inst); Linnaeus Therapeutics (Inst); Merck (Inst); Mural Oncology (Inst); Novartis (Inst); Obsidian Therapeutics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate